Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 4/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | G6PD | P11413 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.44 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CA5A | P35218 | 2/20 | 0.44 |
| ▸ | CA7 | P43166 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL940139 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL9014227 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL9013983 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL7690243 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL18920263 | 1.00 | TYR (0.66) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL9014038 | 0.87 | TYR (0.51) | TYRPOLBKDM4EGAAMAPT | |
| SCHEMBL291103 | 0.86 | TYR (0.49) | TYR | |
| SCHEMBL6582069 | 0.86 | TYR (0.49) | TYRPOLB | |
| SCHEMBL21045067 | 0.86 | SLC5A2 (0.49) | TYRCA12CA9 | |
| SCHEMBL869387 | 0.86 | TYR (0.49) | TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117442531-A | Bright white composition, bright white essence and preparation method thereof | 天津郁美净集团有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-107400653-B | Recombinant escherichia coli containing alpha-glycosidase gene and application thereof | 浙江工业大学 | 2020-10-09 | — | — | CN | disclosed |
| US-9751063-B2 | Emulsion compositions and applications therefor | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2017-09-05 | — | — | US | disclosed |
| EP-3204455-A1 | HYDROPHILIC ETHYLENE OXIDE FREE EMULSIFIER COMPRISING DENDRIMERIC POLYHYDROXYLATED ESTER MOIETIES | Momentive Performance Materials GmbH (DE) | 2017-08-16 | — | — | EP | disclosed |
| EP-3079777-A1 | EMULSION COMPOSITIONS AND APPLICATIONS THEREFOR | Momentive Performance Materials Inc. (US) | 2016-10-19 | — | — | EP | disclosed |
| WO-2016057317-A1 | HYDROPHILIC ETHYLENE OXIDE FREE EMULSIFIER COMPRISING DENDRIMERIC POLYHYDROXYLATED ESTER MOIETIES | MOMENTIVE PERFORMANCE MATERIALS GMBH (DE) | 2016-04-14 | — | — | WO | disclosed |
| WO-2015089035-A1 | EMULSION COMPOSITIONS AND APPLICATIONS THEREFOR | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2015-06-18 | — | — | WO | disclosed |
| US-20150157996-A1 | EMULSION COMPOSITIONS AND APPLICATIONS THEREFOR | MOMENTIVE PERFORMANCE MATERIALS INC. | 2015-06-11 | — | — | US | disclosed |
| WO-2014081715-A1 | COMPOSITIONS AND METHODS FOR THEIR DERMATOLOGICAL USE | VITA NATURALE, LLC (US) | 2014-05-30 | — | — | WO | disclosed |
| EP-2595600-A1 | METHODS FOR INHIBITING TYROSINASE USING AN EXTRACT OF LAMINARIA SACCHARINA | The Procter and Gamble Company (US) | 2013-05-29 | — | — | EP | disclosed |
| WO-2012011906-A1 | METHODS FOR INHIBITING TYROSINASE USING AN EXTRACT OF LAMINARIA SACCHARINA | THE PROCTER & GAMBLE COMPANY (US) | 2012-01-26 | — | — | WO | disclosed |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-11-13 | — | — | US | disclosed |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | BASCHONG WERNER | 2008-10-23 | — | — | US | disclosed |
| US-20070219275-A1 | Use of Benzophenone Uv Filters for Preventing Tanning | BASCHONG WERNER | 2007-09-20 | — | — | US | disclosed |
| EP-1737419-A2 | USE OF BENZOPHENONE UV FILTERS FOR PREVENTING TANNING | Ciba SC Holding AG (CH) | 2007-01-03 | — | — | EP | disclosed |
| US-20060216252-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-09-28 | — | — | US | disclosed |
| EP-1648400-A1 | USE OF HALOGENATED HYDROXYDIPHENYL ETHER COMPOUNDS FOR THE TREATMENT OF THE SKIN | Ciba SC Holding AG (CH) | 2006-04-26 | — | — | EP | disclosed |
| WO-2005094772-A2 | USE OF BENZOPHENONE UV FILTERS FOR PREVENTING TANNING | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-10-13 | — | — | WO | disclosed |
| WO-2005013931-A1 | USE OF HALOGENATED HYDROXYDIPHENYL ETHER COMPOUNDS FOR THE TREATMENT OF THE SKIN | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2005-02-17 | — | — | WO | disclosed |
| EP-1366757-A1 | Use of hydroxydiphenylether compounds for the treatment of skin | Ciba SC Holding AG (CH) | 2003-12-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070219275-A1 | Use of Benzophenone Uv Filters for Preventing Tanning | C1R, CBR3, AOC3 | TYR 18/4885POLB 1805/4885KDM4E 322/4885 |
| US-20150157996-A1 | EMULSION COMPOSITIONS AND APPLICATIONS THEREFOR | POLR1C, POLQ, POLH | TYR 35/4885POLB 16/4885KDM4E 3500/4885 |
| US-20080260667-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | TYR 2/4885POLB 3109/4885KDM4E 1289/4885 |
| US-20080279794-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | TYR 2/4885POLB 3109/4885KDM4E 1289/4885 |
| US-20060216252-A1 | Use of halogenated hydroxydiphenyl ether compounds for the treatment of the skin | MC1R, TYR, MC3R | TYR 2/4885POLB 3028/4885KDM4E 1147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.